Top Markets
Coin of the day
Rapid Dose Therapeutics Corp. Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

DOSE
Rangering i aksjer #32494
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life... Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
Aksjekurs
$0.07339369
Sist synkronisert: 2026-08-17
Markedsverdi
$9.92M
Endring (1 dag)
-4.76%
Endring (1 år)
-48.06%
Land
CA
Handel Rapid Dose Therapeutics Corp. (DOSE)

Kategori

Utbyttehistorikk for Rapid Dose Therapeutics Corp. (DOSE)
Rapid Dose Therapeutics Corp. (aksjesymbol: DOSE) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Rapid Dose Therapeutics Corp. (DOSE) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter